CHUAN HOLDING (01420) plans to issue approximately 207 million new shares to Mr. Pang Yaojie, raising approximately HKD 15,339.5 million in funds.

18:12 19/11/2023

(01420) announced that Pang Yaojie will be transferred from a non-executive director to an executive director as of January 1, 2024.

Chuan Holding (01420) announced that Pang Yaojie will be reappointed as an executive director from a non-executive director, effective January 1, 2024. Pang Yaojie will also become the Chairman of the Board of Directors and continue to serve as the Chairman of the Nomination Committee. On November 17, 2023, the company entered into a subscription agreement with Pang Yaojie. The company plans to issue approximately 207 million new shares to Pang Yaojie, accounting for approximately 16.67% of the enlarged share capital. The subscription price is HKD 0.074 per share, with a total consideration of approximately HKD 15,339,500 in cash.

Orient: The relative return value of food and beverage is highlighted; it is recommended to increase the allocation ratio to the consumer sector.

At the CIIE, JD Health signed agreements with more than 20 brands including Pfizer and Merck; in the first three quarters, it launched more than 100 new drugs, and JD HEALTH (06618) remains firmly the largest pharmaceutical retail platform in China.

HK Stock Market Move | AI hardware stocks opened sharply lower; Democrats sweep Congress, AI regulatory concerns escalate, and the U.S. stock market crash spreads to Asia-Pacific markets.

Orient: The relative return value of food and beverage is highlighted; it is recommended to increase the allocation ratio to the consumer sector.

HK Stock Market Move | AI hardware stocks opened sharply lower; Democrats sweep Congress, AI regulatory concerns escalate, and the U.S. stock market crash spreads to Asia-Pacific markets.